There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

In its bid to resist a court order to unfreeze grants, the Trump administration reveals a laser focus on eliminating ...